Existing treatment options for the condition include several FDA-approved medications, along with a range of behavioral therapies and support programs, though researchers and clinicians have continued searching for additional treatment approaches given that no single existing option works effectively for every patient
GLP-1RAs reduce food intake and body weight by acting primarily in the brain, but theres a debate about where in the brain these drugs work
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
We believe everyone deserves access to effective, evidence-based therapies
Consulter un professionnel de sant en cas de problmes cardiaques ou de tension artrielle.
You can take the free assessment quiz to get started